Ida D’Onofrio

Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Kevin J. Harrington, Stéphane Temam, Hisham Mehanna et al. · Journal of Clinical Oncology · 2015 · 103 citations

Medicine, Oncology, Radiation Oncology +15

Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus

Florent Carsuzaa, M. Lapeyre, Vincent Grégoire et al. · Radiotherapy and Oncology · 2021 · 27 citations · Full text

Medicine, Oncology, Surgery +10

Final analysis: A randomized, blinded, placebo (P)-controlled phase III study of adjuvant postoperative lapatinib (L) with concurrent chemotherapy and radiation therapy (CH-RT) in high-risk patients with squamous cell carcinoma of the head and neck (SCCHN).

Kevin J. Harrington, Stéphane Temam, Anil D′Cruz et al. · Journal of Clinical Oncology · 2014 · 26 citations

Medicine, Oncology, Radiation Oncology +17

A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group

Francesca De Felice, Elisa D’Angelo, Rossana Ingargiola et al. · La radiologia medica · 2020 · 24 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients

Yungan Tao, Anne Aupérin, Christian Sire et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 16 citations

Medicine, Oncology, Radiation Oncology +7